Asia-Pacific Laboratory Centrifuge Market Size, Share, Trends and Growth Forecast Report Segmented By Product, Rotor Design, Intended Use, Application, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, Rest of APAC) - Industry Analysis, 2026-2034

ID: 4812
Pages: 295

Market Size, 2025

$378.40 Mn

Market Estimate, 2026

$394.18 Mn

Market Forecast, 2034

$546.56 Mn

CAGR, 2026–2034

4.17%

Asia Pacific Laboratory Centrifuge Market Size, Growth, Trends & Forecast (2026–2034)

The Asia Pacific laboratory centrifuge market size was valued at USD 378.40 million in 2025, is estimated at USD 394.18 million in 2026, and is projected to reach USD 546.56 million by 2034, registering a compound annual growth rate (CAGR) of 4.17% during the forecast period from 2026 to 2034. Driven by the rising prevalence of chronic diseases, advancements in life sciences and molecular diagnostics, increasing R&D investments, and technological integration like IoT-enabled remote monitoring, the market continues to expand steadily across the region.

Key Executive Metrics (At-a-Glance)

  • 2025 Base Valuation: USD 378.40 Million
  • 2026 Current Valuation: USD 394.18 Million
  • 2034 Forecast Valuation: USD 546.56 Million
  • Compound Annual Growth Rate (CAGR): 4.17% (2026–2034)
  • Leading Country Market (Historical/Overall): Japan
  • Fastest-Growing Country Market: China (projected to lead and expand significantly due to massive pharmaceutical and industrial growth)

Core Market Drivers

  • Rise in Chronic Diseases: Increasing incidence of conditions like cancer, HIV/AIDS, malaria, and tuberculosis requiring robust molecular diagnostics and sample separation.
  • Technological Innovations: Integration of IoT features, automated electric brakes, and precision speed control into modern centrifuges for seamless lab workflows.
  • Pharma & Biotech Expansion: Surging public and private investments in medical research and generic drug manufacturing across developing economies.

Primary Market Restraints & Challenges

  • Cost & Lifespan Constraints: High capital expenditure for advanced equipment and concerns regarding hardware lifespans.
  • Operational Hazards: Risks associated with potential mechanical failures and the generation of toxic aerosols during operation.

Asia Pacific Laboratory Centrifuge Market Segmentation Breakdown

Segment Category Largest Segment Fastest-Growing Segment / Other Key Categories
By Product Equipment Equipment (Fastest-Growing)
By Rotor Design Swinging Bucket Rotors Fixed Angle Rotors (Fastest-Growing)
By Intended Use Clinical Centrifuges Preparative Ultracentrifuges (Fastest-Growing)
By Application Diagnostic Genomics (Fastest-Growing)
By End User Pharmaceutical & Biotech Pharmaceutical (Fastest-Growing)
By Country Japan China (Fastest-Growing)

Major Industry Players Profiled

Key market participants shaping the Asia Pacific landscape include Thermo Fisher Scientific, Inc., QIAGEN, Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Sigma Laborzentrifugen GmbH, Neuation, Hitachi Koki Co., Ltd., and Harvard Bioscience, Inc.

To learn more about this report, icon Download Free Sample Report

Asia Pacific Laboratory Centrifuge Market Size 

The Asia Pacific Laboratory Centrifuge Market is projected to grow from USD 378.40 million in 2025 to USD 394.18 million in 2026 and reach USD 546.56 million by 2034, registering a CAGR of 4.17% during the forecast period from 2026 to 2034.

Market Data Forecast estimates APAC Laboratory Centrifuge Market to reach USD 546.56 million by 2034.

The laboratory centrifuge is a regional demand for separation equipment essential in clinical diagnostics, pharmaceutical, and industrial applications. These devices utilize centrifugal force to separate components of a mixture based on density differences, ensuring precise sample preparation for downstream analysis. The number of tertiary education institutions in Asia increased between 2015 and 2020, driving higher enrollment in life sciences programs that require sophisticated laboratory equipment for practical training and research activities. This growing academic and healthcare infrastructure directly influences the procurement patterns of laboratory centrifuges,s ensuring consistent demand across the region.

MARKET DRIVERS

Expansion of Pharmaceutical Research and Development Activities

The expansion of pharmaceutical research and development activities is significantly propelling the growth of the Asia Pacific Laboratory Centrifuge Market. Pharmaceutical companies increasingly invest in drug discovery pipelines requiring high-precision equipment for isolating cellular components and analyzing molecular structures. These investments facilitate the development of novel therapeutics and vaccines, which require rigorous testing protocols involving multiple centrifugation steps for purity assessment and component isolation. The presence of major generic drug manufacturers in countries like China, India,  and South Korea further amplifies the need for reliable and efficient centrifuges to maintain quality control standards. The continuous growth in pharmaceutical R&D expenditure directly correlates with increased procurement of laboratory centrifuges d, driving market expansion across the region.

Rising Prevalence of Chronic Diseases and Diagnostic Testing

The rising prevalence of chronic diseases and diagnostic testing is additionally boosting the growth of the Asia Pacific laboratory centrifuge market. Healthcare providers increasingly rely on diagnostic tests that require sample preparation through centrifugation to detect biomarkers associated with conditions such as diabetes, cardiovascular diseases, and cancer. According to the World Health Organization, non-communicable diseases account for 75% of all deaths in the Western Pacific Region, highlighting the urgent need for expanded diagnostic infrastructure,e including laboratory centrifuges for routine blood and urine analysis. This surge in testing volume requires laboratories to process larger sample batches efficiently, thereby prompting upgrades to high-capacity and automated centrifuge systems. Government initiatives aimed at strengthening primary healthcare networks also contribute to this trend by equipping rural clinics with basic diagnostic tools, including compact centrifuges. The growing aging population in countries like Japan and China further exacerbates the demand for chronic disease monitoring, thereby sustaining long-term growth in the laboratory centrifuge segment across the Asia Pacific region.

MARKET RESTRAINTS

High Initial Investment and Maintenance Costs

The high initial investment and maintenance costs are limiting accessibility for smaller laboratories and healthcare facilities in developing nations, which is limiting the growth of the Asia Pacific laboratory centrifuge market. Advanced centrifuges featuring refrigeration units, digital controls, and high-speed capabilities command premium prices that exceed the budget constraints of many public health institutions and independent diagnostic centers. The healthcare facilities in low-income Asian countries lack adequate funding for capital equipment purchases, forcing them to rely on outdated or shared instruments that compromise diagnostic efficiency. The scarcity of trained technicians capable of servicing complex centrifuge models further escalates downtime and repair expenses,s particularly in rural areas where technical support is limited. Additionally, fluctuating currency exchange rates in emerging markets increase the cost of imported components and spare parts, making long-term ownership economically challenging. These financial barriers prevent widespread adoption of modern centrifugation technology, thereby slowing penetration in price-sensitive segments, despite the clear clinical benefits offered by advanced systems.

Stringent Regulatory Compliance and Certification Requirements

The stringent regulatory compliance and certification requirements by prolonging product approval timelines and increasing operational complexity for manufacturers that is also degrading the growth of the Asia Pacific laboratory centrifuge market. Each country within the region maintains distinct regulatory frameworks governing medical device safety performance standards and electromagnetic compatibility, which necessitate extensive testing and documentation before entry. Medical Device Directive harmonization efforts remain incomplete, resulting in fragmented approval processes that delay product launches by an average of 6 to 9 months across different member states. The number of rejected medical device applications due to insufficient clinical data or noncompliance with local standards has increased, reflecting heightened scrutiny that burdens manufacturers with additional compliance costs. Small and medium enterprises often lack the resources to navigate these complex regulatory landscapes effectively, leading to reduced product portfolios and limited presence. Furthermore, frequent updates to international standards such as ISO 17025 for laboratory competence require continuous adaptation of manufacturing processes and quality assurance protocols.

MARKET OPPORTUNITIES

Integration of Automation and Digital Connectivity in Laboratory Equipment

The integration of automation and digital connectivity in laboratory equipment are enhancing operational efficiency and data integrity in modern laboratories, which is substantially to create new opportunities for the growth of the Asia Pacific laboratory centrifuge market. Smart centrifuges equipped with Internet of Things capabilities enable remote monitoring,g predictive maintenance,ce and seamless integration with laboratory information management systems, reducing manual errors and improving workflow productivity. This technological evolution appeals to large hospital networks and contract research organizations seeking to optimize resource utilization and minimize turnaround times for critical test results. Manufacturers who prioritize software development and user-friendly interfaces can differentiate their offerings in a competitive landscape, while addressing the growing demand for traceability and audit trails in regulated environments.

Growing Investment in Biotechnology and Genomics Research

The growing investment in biotechnology and genomics research for specialized high-performance separation equipment is another factor boosting the growth of the Asia Pacific laboratory centrifuge market. Governments and private entities are increasingly funding initiatives focused on personalized medicine, genetic sequencing, and stem cell therapy, which require precise and gentle sample preparation methods provided by advanced centrifuges. These applications demand equipment with precise temperature control and variable speed settings to preserve sample integrity during delicate separation processes. The emergence of biohubs in countries like Singapore, South Korea, and Australia further concentrates research activities, creating localized demand clusters for premium centrifuge models.

MARKET CHALLENGES

Shortage of Skilled Laboratory Technicians and Training Gaps

The shortage of skilled laboratory technicians and training gaps, thereby limiting the effective utilization of advanced equipment and increasing operational risks,s is a major challenge for the Asia Pacific laboratory centrifuge market. Modern centrifuges with complex programming options and safety features require operators with specialized knowledge to ensure optimal performance and prevent sample loss or equipment damage. The laboratory staff in developing Asian countries receive formal training on new equipment operations,resulting ino higher error rates and increased maintenance calls that disrupt workflow efficiency. This skills gap forces laboratories to either delay equipment upgrades or invest heavily in internal training programs,ams which strains limited resources. Furthermore, high turnover rates among technical staff exacerbate the problem by creating continuous cycles of retraining and knowledge loss. Manufacturers face the additional burden of providing comprehensive user support and educational materials to bridge these competency gaps.

Supply Chain Disruptions and Raw Material Volatility

The supply chain disruptions and raw material volatility are causing production delays and increasing manufacturing costs for equipment producers, which is acting as a barrier to the growth of the Asia Pacific laboratory centrifuge market. The reliance on specialized components such as high-precision motors, sensors, and corrosion-resistant materials makes manufacturers vulnerable to global supply chain interruptions and price fluctuations. Geopolitical tensions and export restrictions impact profit margins for centrifuge manufacturers, who struggle to pass these costs onto price-sensitive customers. These disruptions force companies to maintain higher inventory levels, tying up capital and increasing storage expenses, while simultaneously risking obsolescence of stored components. Additionally, inconsistent quality of locally sourced materials in some regions necessitates rigorous incoming inspection processes that further slow production cycles. The unpredictability of supply chains undermines planning accuracy and customer satisfaction as delivery commitments become difficult to honor.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2025 to 2034

Base Year

2025

Forecast Period

2026 to 2034

Segments Covered

By Product, Rotor Design, Intended Use Application, End User, By Region

Various Analyses Covered

Global, Regional,l and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Countries Covered

India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam
Philippines, Indonesia, Singapore, Rest of APAC

Market Leaders Profiled

Thermo Fisher Scientific, Inc.
QIAGENBecton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Sigma LaborzentrifugenGmbHNeuationHitachi Koki Co., Ltd., Harvard Bioscience, Inc.

SEGMENTAL ANALYSIS

By Product Insights

The equipment segment was the largest, holding 45.3% of the Asia Pacific Laboratory Centrifuge Market share in 2025 due to the fundamental necessity of centrifuges as primary separation tools in clinical and research laboratories. The continuous expansion of healthcare infrastructure and the increasing establishment of new diagnostic centers, across emerging economies. As per the study, capital expenditure on medical equipment in regional healthcare facilities rose by 12% annually, reflecting prioritized investment in essential diagnostic hardware that forms the backbone of laboratory operations. The replacement cycle of aging equipment in established markets like Japan and Australia further contributes to steady revenue streams for manufacturers. Additionally, technological advancements such as refrigerated capabilities and noise reduction features encourage upgrades in existing facilities. The high initial cost of equipment compared to accessories ensures that this segment captures the majority of market value.

The accessories segment is projected to witness the fastest CAGR of 6.5% during the forecast period, with the need for specialized rotors, tubes,s and adapters to accommodate diverse sample types. The expanding scope of laboratory applications requires specific configurations for blood banking, microbiology,gy and molecular biology tasks. The adoption of single-use centrifuge tubes in diagnostic laboratories across India and China grew due to strict infection control protocols mandating disposable consumables to prevent cross-contamination. The recurring nature of accessory purchases ensures consistent revenue flow independent of major equipment procurement cycles. Furthermore, the introduction of high-throughput automation systems necessitates customized racks and carriers that integrate seamlessly with robotic handlers. Manufacturers are increasingly focusing on offering comprehensive accessory portfolios to lock in customers and generate recurring income.

By Rotor Design Insights

The fixed angle rotors segment held a dominant share of the Asia Pacific Laboratory Centrifuge Market in 2025, owing to their superior speed capabilities and efficiency in pelleting particles for routine clinical diagnostics. These rotors are preferred in high-volume laboratories because they allow for faster separation times and higher relative centrifugal forces, which are critical for processing large batches of blood and urine samples. The simplicity of design reduces the risk of mechanical failure and lowers maintenance costs, making them an economical choice for public health institutions with limited budgets. Their ability to handle standard tube sizes without complex balancing requirements further enhances their appeal among laboratory technicians with varying levels of expertise.

The swinging bucket rotors segment is likely to register the fastest CAGR of 7.2% from 2026 to 2034 with the rising demand for density gradient separations in advanced research and biotechnology applications. This growth is attributed to the unique ability of swinging bucket rotors to separate components based on density rather than size, which is essential for isolating viruses, organelles, and nucleic acids. The procurement of specialized swinging bucket rotors capable of handling delicate biological samples with minimal shear stress is also increasing. The increasing focus on personalized medicine and regenerative therapies requires precise separation techniques that only swinging bucket designs can provide. Furthermore, academic institutions are upgrading their laboratories to support graduate-level research projects that demand versatile instrumentation.

By Application Insights

The diagnostic segment held a dominant share of the Asia Pacific laboratory centrifuge market in 2025, with the high volume of routine clinical tests performed in hospitals and independent diagnostic centers across the region. The prevalence of infectious diseases and chronic conditions necessitates frequent blood and urine analysis, which relies heavily on centrifugation for sample preparation prior to automated analysis. The integration of centrifuges into pre-analytical workflows ensures consistency and accuracy in test results, which is important for patient diagnosis and treatment planning. Government initiatives aimed at improving primary healthcare access also contribute to this dominance by equipping rural clinics with basic diagnostic tools.

The microbiology segment is likely to grow at the fastest CAGR of 8.1% from 2026 to 2034 with the increasing incidence of antimicrobial resistance and emerging infectious diseases. The need for rapid identification of pathogens through culture and sensitivity testing requires efficient separation of bacterial cells from clinical specimens. The number of microbiology laboratories accredited under international standards in the region grew in 2023, reflecting improved capacity for pathogen detection and surveillance. The rise in hospital-acquired infections further necessitates robust microbiological testing capabilities to monitor and control outbreaks effectively. Additionally, the development of new diagnostic kits for viral and bacterial infections often requires specific centrifugation steps for extraction and purification.

By End User Insights

The hospital segment was the largest, holding 36.1% of the Asia Pacific Laboratory Centrifuge Market share in 2025 due to the comprehensive range of diagnostic services offered within large healthcare facilities that require extensive laboratory support. Hospitals process a vast array of patient samples daily, ranging from emergency trauma cases to routine checkups, necessitating a diverse fleet of centrifuges for different departments. The presence of in-house laboratories allows hospitals to maintain greater control over test quality and turnaround time, which is crucial for acute care management. Furthermore, teaching hospitals associated with medical universities serve as training grounds for future professionals, ensuring continuous demand for educational and clinical-grade equipment.

The biotech segment is expected to witness the fastest CAGR of 9.3% from 2026 to 2034, with the surge in pharmaceutical research and development activities focused on biologics and gene therapy. Biotechnology companies require high-precision centrifuges for cell culture harvesting, protein purification,n and nucleic acid isolation, which are steps in the development of novel therapeutics and vaccines. The shift towards personalized medicine and regenerative therapies further amplifies the need for specialized centrifugation solutions that can handle sensitive biological materials with minimal degradation. Contract research organizations are also expanding their capacities to support global pharmaceutical clients, creating additional demand for high-performance laboratory equipment.

COUNTRY LEVEL ANALYSIS

China Laboratory Centrifuge Market Analysis

China was the top performer in the Asia Pacific Laboratory Centrifuge Market by occupying a 54.1% share in 2025, with its massive healthcare infrastructure and aggressive government investments in biomedical research and development. The country serves as a manufacturing hub for laboratory equipment while simultaneously being a major consumer due to its large population and rising healthcare demands. According to the National Health Commission of China, the number of medical institutions exceeded 1 million in 2023, with significant upgrades in laboratory capabilities to support universal health coverage initiatives. The presence of numerous domestic manufacturers offers cost-effective solutions that cater to both public hospitals and private diagnostic chains. Furthermore, the Belt and Road Initiative facilitates the export of Chinese-made centrifuges to neighboring countries, enhancing the regional influence of local brands.

India Laboratory Centrifuge Market Analysis

India laboratory centrifuge market held next by holding 31.2% of share in 2025 with the growing network of diagnostic centers and increasing awareness of preventive healthcare among the population. The proliferation of private healthcare providers and government schemes aimed at improving rural healthcare access necessitates the deployment of affordable and durable laboratory equipment. The rise in medical tourism also contributes to market growth, as hospitals upgrade their facilities to meet international accreditation standards. Local manufacturers are gaining traction by offering competitive pricing and after-sales support tailored to the specific needs of the Indian market. The increasing prevalence of lifestyle diseases further drives the demand for diagnostic services, thereby sustaining the long-term growth trajectory of the laboratory centrifuge market in India.

Japan Laboratory Centrifuge Market Analysis

Japan laboratory centrifuge market is likely to grow with its aging population and high standards for medical diagnostics and research excellence. The preference for high precision automated and connected laboratory instruments that integrate seamlessly with existing hospital information systems. The strong regulatory framework ensures high quality standards for medical devices, fostering trust in premium international brands. Additionally, the focus on personalized medicine and regenerative therapies drives demand for specialized centrifuges capable of handling delicate biological samples.

South Korea Laboratory Centrifuge Market Analysis

South Korea laboratory centrifuge market growth is fueled by its robust biotechnology sector and advanced healthcare infrastructure that emphasizes innovation and digital integration. The country is a global leader in semiconductor and electronics manufacturing,g which translates into high-quality production of laboratory instruments featuring smart connectivity and precision engineering. The government's support for precision medicine projects further accelerates the uptake of advanced diagnostic tools. Local companies are increasingly collaborating with global players to develop next-generation laboratory solutions. The high literacy rate and technical expertise among laboratory staff facilitate the rapid adoption of complex instrumentation.

Australia Laboratory Centrifuge Market Analysis

Australia laboratory centrifuge market growth is propelled by the high regulatory standards and a strong focus on research and development in medical sciences. The well-funded public healthcare systems and prestigious university research institutes require state-of-the-art laboratory equipment for clinical and academic purposes. The geographic dispersion of healthcare facilities creates demand for durable and low-maintenance equipment suitable for remote locations. Additionally, the strong collaboration between industry and academia fosters innovation in laboratory technologies.

COMPETITIVE LANDSCAPE

The Asia Pacific Laboratory Centrifuge Market features a moderately consolidated competitive landscape characterized by the presence of established global manufacturers and emerging local players. Global companies dominate the premium segment by offering advanced technologies such as automation, digital connectivity, and high-speed capabilities that cater to large hospitals and research institutions. Local manufacturers compete primarily on price and customization, servingsmall-l tmedium-sizeded laboratories and public health facilities in developing nations. The market witnesses intense competition driven by continuous product innovation and the need to comply with varying regulatory standards across different countries. Key participants focus on strengthening distribution networks and enhancing after-sales support to differentiate themselves in a price-sensitive environment. Strategic collaborations with local distributors enable global brands to navigate complex regulatory landscapes and reach remote areas effectively.

KEY MARKET PLAYERS

Some of the companies that are playing a dominant role in the Asia-Pacific Laboratory Centrifuge Market include

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Sigma Laborzentrifugen GmbH
  • Neuation
  • Hitachi Koki Co., Ltd.
  • Harvard Bioscience, Inc.

TOP LEADING PLAYERS IN THE MARKET

  • Thermo Fisher Scientific maintains a strong presence in the Asia Pacific Laboratory Centrifuge Market through its comprehensive portfolio of high-performance separation equipment tailored for clinical and research applications. The company focuses on integrating digital connectivity features into its centrifuge lines to enhance laboratory workflow efficiency and data traceability. Recent initiatives include expanding manufacturing capabilities in Singapore to serve regional demand more effectively while reducing supply chain lead times. Thermo Fisher also invests heavily in training programs for laboratory technicians across emerging markets to ensure optimal utilization of advanced instruments. Their commitment to innovation is evident in the launch of refrigerated models with improved energy efficiency, which aligns with sustainability goals of major healthcare institutions.
  • Eppendorf SE contributes significantly to the Asia Pacific Laboratory Centrifuge Market by offering precision-engineered instruments known for their durability and user-friendly interfaces. The company has strengthened its position by establishing dedicated research and development centers in China and India to customize products for local needs. Eppendorf recently launched a series of compact centrifuges designed for small laboratories and point-of-care settings, which addresses the growing demand for space-efficient solutions. The firm also emphasizes sustainable practices by introducing eco-friendly packaging and energy-saving modes in its newer models. Collaborations with local distributors have enhanced market penetration in Southeast Asian countries where healthcare infrastructure is rapidly expanding. Eppendorf’s focus on after-sales service and comprehensive warranty programs builds trust among healthcare providers and academic institutions.
  • Beckman Coulter Inc. plays a pivotal role in the Asia Pacific Laboratory Centrifuge Market by providing automated solutions that integrate seamlessly with high-throughput diagnostic workflows. The company has expanded its service network in key markets such as Japan and Australia to ensure rapid response times for maintenance and repairs. Beckman Coulter recently introduced smart centrifuges equipped with remote monitoring capabilities, allowing laboratory managers to track usage patterns and predict maintenance needs proactively. The firm actively participates in industry conferences and scientific symposiums to showcase technological advancements and engage with key opinion leaders. Strategic partnerships with hospital networks have facilitated the deployment of integrated pre-analytical systems that include centrifugation modules.

MARKET  SEGMENTATION

This research report on the Asia Pacific Laboratory Centrifuge Market has been segmented and sub-segmented into the following categories.

By Product

  • Equipment
  • Accessories

By Rotor Design

  • Swinging Bucket Rotors
  • Fixed Angle Rotors
  • Vertical Rotors

By Intended Use

  • General-purpose Centrifuges
  • Clinical Centrifuges
  • Preclinical Centrifuges
  • Preparative Ultracentrifuges

By Application

  • Diagnostic
  • Microbiology
  • Proteomics
  • Genomics

By End User

  • Hospital
  • Biotech
  • Pharmaceutical

By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Frequently Asked Questions

1. What is the Asia Pacific laboratory centrifuge market size?

The market was valued at USD 0.39 billion in 2025 and is estimated at USD 0.40 billion in 2026. It is projected to reach USD 0.52 billion by 2034.

2. Why is the Asia Pacific laboratory centrifuge market growing?

Key factors include rising chronic disease prevalence, advances in life sciences and molecular diagnostics, increasing pharmaceutical and biotechnology R&D investments, and technological improvements in centrifuges.

3. Who are the major players in the Asia Pacific laboratory centrifuge market?

Major companies profiled include Thermo Fisher Scientific, QIAGEN, Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Sigma Laborzentrifugen, Neuation, Hitachi Koki, and Harvard Bioscience.

4. How is the Asia Pacific laboratory centrifuge market segmented?

The market is segmented by product, rotor design, intended use, application, end user, and country.

Related Reports

Click for Request Sample